Skip to main content
. 2019 Jul 23;9:10689. doi: 10.1038/s41598-019-47069-9

Figure 5.

Figure 5

Tat.AG and HIV-1 CRF02_AG isolates induced higher LTR transactivation and increased HAT activity compared to Tat.B and HIV-1 clade-B. (A,B) Levels of CAT enzyme (A) and HAT activity (B) in U38 cells treated for 48 h with Tat.AG or Tat.B (10 to 1000 ng/ml). HI-Tat: heat-inactivated Tat proteins. Comparative p-values, or p-values compared to cells treated with HI-Tat proteins are shown. (CF) HAT activity in primary human monocytes (C,D) and MDM (E,F) exposed to HIV-1 CRF02_AG or clade-B for 6 to 24 h. *P < 0.05, **P < 0.01, ***P < 0.001, #P < 0.0001. (AC,E) errors bars represent SD. (D,F) errors bars represent SEM.